The surprising connection between cellular fatty acids, endothelial dysfunction, the glycocalyx, blood glucose, nitric oxide, and cardiovascular disease.
When most people think about cardiovascular disease, they think about cholesterol. They think about low-density lipoprotein (LDL), statins, clogged arteries, heart attacks, and strokes.
But what if we’re overlooking something important?
What if the health of the cells lining our arteries—and the protective layer covering those cells—plays a critical role in how cardiovascular disease develops?
And what if inadequate amounts of certain omega-3 fatty acids contribute to an environment that makes those protective systems more vulnerable?
These questions are central to a developing framework I call The Cholesterol Matrix.
For more than three decades, I’ve encouraged people to look beyond individual laboratory numbers and understand how nutrition, metabolism, and cellular health influence the body.
When it comes to cardiovascular disease, that perspective is especially important.
We must understand cholesterol and the particles that carry it. But we must also consider insulin resistance, inflammation, endothelial cell function, nitric oxide production, cellular fatty acid status, and a remarkable protective structure called the endothelial glycocalyx.
And as you’ll discover, researchers have demonstrated that elevated blood glucose can affect this protective structure much faster than most people might imagine.
The more we understand how these systems interact, the better equipped we become to address the factors contributing to cardiovascular disease.
The Protective Layer Most People Have Never Heard Of
Every blood vessel in your body is lined with endothelial cells. These cells help regulate blood flow, inflammation, blood clotting, and vascular health.
Covering the blood-facing surface of these cells is a delicate, gel-like structure called the endothelial glycocalyx.
Imagine a microscopic protective carpet lining the inside of your arteries.
But this protective layer is much more sophisticated than an ordinary carpet.
The glycocalyx contains specialized molecules called proteoglycans, glycoproteins, and glycosaminoglycans. These structures are connected to the endothelial cell surface and help regulate how blood interacts with the artery wall.
The glycocalyx performs several important functions.
It helps regulate the movement of certain molecules across the blood vessel lining, influences interactions between circulating immune cells and endothelial cells, and participates in sensing the mechanical forces created by flowing blood.
That mechanical force is called shear stress.
When blood flows across the glycocalyx, mechanical signals can activate an enzyme called endothelial nitric oxide synthase (eNOS), which produces nitric oxide (NO).
Nitric oxide helps blood vessels relax, supports healthy circulation, and helps regulate platelet activity and inflammation.
Here’s the connection: The glycocalyx helps detect blood flow, while endothelial cells produce nitric oxide in response.
They work together.
And when this communication becomes impaired, vascular health can suffer.
The Vicious Circle: Which Gets Damaged First?
This is where the science becomes especially interesting.
In 2018, researchers published a scientific review in Matrix Biology titled Endothelial Cell Dysfunction and Glycocalyx – A Vicious Circle.
The researchers described how glycocalyx degradation and endothelial dysfunction can reinforce one another.
For example, elevated blood glucose, oxidative stress, inflammation, and other vascular stressors may contribute to glycocalyx damage.
When the glycocalyx becomes compromised, endothelial cells may lose some of their ability to respond normally to blood flow.
This can interfere with nitric oxide signaling.
Meanwhile, dysfunctional endothelial cells can generate additional inflammatory and oxidative stress signals that contribute to further glycocalyx degradation.
Think about that.
Damage to the glycocalyx may contribute to endothelial dysfunction, and endothelial dysfunction may contribute to even more glycocalyx damage.
It’s a vicious circle.
Although researchers have demonstrated important parts of this relationship experimentally, we do not yet know which structure becomes damaged first in every person or every form of cardiovascular disease.
But one thing is clear: endothelial cells and the glycocalyx are closely connected.
And this relationship becomes even more interesting when we examine what researchers discovered about elevated blood glucose.
The Human Experiment That Revealed How Vulnerable the Glycocalyx Can Be
In 2006, researchers led by Max Nieuwdorp published a remarkable study in the scientific journal Diabetes.
The study was titled Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides With Endothelial Dysfunction and Coagulation Activation In Vivo.
The researchers wanted to understand whether elevated blood glucose could affect the protective glycocalyx lining blood vessels.
They recruited 10 healthy men and experimentally elevated their blood glucose under carefully controlled conditions.
Then they measured changes in estimated systemic endothelial glycocalyx volume.
What they discovered was remarkable.
During the control condition, estimated glycocalyx volume averaged approximately 1.7 liters.
During experimentally induced hyperglycemia—meaning elevated blood glucose—the estimated volume declined to approximately 0.8 liters.
That’s a reduction of approximately 53%.
And the experiment involved only several hours of elevated blood glucose.
It’s important to understand what the researchers measured. They used specialized circulating tracers to estimate the glycocalyx’s systemic distribution volume. They did not directly observe every artery losing half its protective coating.
Nevertheless, the findings demonstrated that acute metabolic stress could substantially alter a measurement associated with this protective vascular structure.
But that wasn’t the only finding.
The researchers also observed:
-
- Impaired endothelial function.
- Increased circulating hyaluronan, a molecule associated with glycocalyx structure and shedding.
- Increased activation of blood-clotting pathways.
In other words, changes in glycocalyx-related measurements occurred alongside changes in endothelial function and coagulation activity.
This was more than an isolated change in a laboratory measurement. Several systems involved in vascular protection were affected during the same experiment.
The Antioxidant Finding Makes This Even More Interesting
The researchers also investigated an antioxidant-related compound called N-acetylcysteine (NAC).
During the high-glucose condition, estimated glycocalyx volume declined to approximately 0.8 liters.
With NAC administered during hyperglycemia, the estimated volume was approximately 1.4 liters.
This suggested that oxidative stress may contribute to the glycocalyx changes associated with elevated glucose.
The study was small, and these results do not establish NAC as a treatment for glycocalyx damage or cardiovascular disease.
But the biological implication is important.
Oxidative stress may be one of the pathways connecting elevated blood glucose, endothelial dysfunction, and glycocalyx deterioration.
And that brings us directly into the metabolic-health component of The Cholesterol Matrix.
How Elevated Blood Glucose Can Become a Problem for the Glycocalyx
Here’s something fascinating about glucose.
The body uses glucose-derived molecules as building blocks when producing certain components of the glycocalyx.
So glucose itself isn’t inherently the enemy.
In fact, the endothelial cell uses specific biochemical pathways to assemble and maintain this protective structure.
However, chronically elevated blood glucose can create a very different biological environment.
High glucose can promote oxidative stress and the formation of advanced glycation end products (AGEs).
These compounds form when sugars react with proteins, lipids, and other molecules through nonenzymatic processes.
AGEs can interact with a cellular receptor called the receptor for advanced glycation end products (RAGE).
Activation of this pathway can increase inflammatory and oxidative signaling.
These conditions can also influence enzymes involved in degrading glycocalyx components, including heparanase, hyaluronidases, and certain matrix metalloproteinases.
Think of it this way.
Inside the endothelial cell, glucose-derived molecules can help supply the building materials needed to maintain the glycocalyx.
But when blood glucose becomes chronically elevated, the resulting metabolic stress can activate processes that damage the very structure the cell is trying to maintain.
It’s almost like having a construction crew building a protective wall while a demolition crew is working against it.
And remember, the glycocalyx and endothelial cells are biologically interconnected.
As glycocalyx function deteriorates, blood-flow sensing and endothelial signaling may become impaired.
As endothelial dysfunction increases, additional oxidative and inflammatory stress may contribute to further glycocalyx damage.
This helps explain why insulin resistance and poor glucose regulation deserve serious attention in cardiovascular prevention—even before someone develops diagnosed diabetes.
The 2006 experiment involved sustained, experimentally induced hyperglycemia. It does not mean that every ordinary rise in blood glucose produces a 53% reduction in glycocalyx volume.
Nevertheless, it provides direct human evidence that the vascular environment can respond rapidly to metabolic stress.
The Missing Piece: What Happens When Endothelial Cells Don’t Have Adequate EPA and DHA?
Now let’s introduce another important component of The Cholesterol Matrix.
Every endothelial cell is surrounded by a plasma membrane.
This membrane isn’t simply a protective covering. It’s a highly organized structure containing phospholipids, cholesterol, proteins, and other molecules that help regulate cellular communication and function.
The fatty acids incorporated into membrane phospholipids influence membrane organization, physical properties, and certain signaling processes.
Two important omega-3 fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
These fatty acids play important roles in cellular biology.
DHA is particularly important for membrane structure and organization, while EPA participates in membrane biology and serves as a precursor to signaling molecules involved in inflammatory regulation.
Both EPA and DHA can influence endothelial function through several biological pathways.
Laboratory studies have demonstrated that these fatty acids can affect endothelial membrane properties, nitric oxide signaling, oxidative stress, and inflammatory responses.
Now consider something important.
If the fatty acid environment of endothelial cells is unfavorable, could that influence how effectively those cells maintain and protect the glycocalyx?
This is one of the central questions behind my Cholesterol Matrix hypothesis.
Low EPA and DHA status does not automatically mean someone has endothelial dysfunction. Endothelial cells have multiple mechanisms for regulating their membranes, and researchers have not established a specific EPA or DHA level below which glycocalyx damage necessarily occurs.
Nevertheless, the biological connection is worth investigating.
Because the glycocalyx depends on the endothelial cells beneath it.
Why Healthy Endothelial Cells Matter to the Glycocalyx
Here’s something that deserves greater attention.
The endothelial glycocalyx is not an independent structure floating inside our arteries.
It is produced, anchored, and maintained by endothelial cells.
Components of the glycocalyx are connected to the endothelial plasma membrane through molecules such as glypican-1 and syndecans.
These molecules participate in the communication between blood flow, the glycocalyx, and the endothelial cell.
This means that the condition of endothelial cells can influence the condition of the glycocalyx.
When endothelial cells become dysfunctional, they may produce more reactive oxygen species, activate inflammatory pathways, and increase the activity of enzymes that degrade glycocalyx components.
Consequently, endothelial dysfunction can contribute to glycocalyx deterioration.
But here’s where the relationship becomes even more interesting.
When the glycocalyx becomes damaged, it may no longer communicate as effectively with the endothelial cells beneath it.
That can interfere with normal responses to blood flow, including nitric oxide signaling.
In other words, unhealthy endothelial cells may contribute to glycocalyx damage, and a damaged glycocalyx may contribute to further endothelial dysfunction.
This is the vicious circle described in the scientific literature.
Now imagine introducing another potential influence into this relationship: inadequate EPA and DHA availability.
Could Omega-3 Status Help Drive—or Interrupt—the Vicious Circle?
This is where I believe the research becomes especially compelling.
EPA and DHA influence more than membrane physical properties.
They can also participate in several processes relevant to endothelial health.
First, membrane organization. The fatty acid composition of endothelial membranes can influence their physical properties and the activity of certain membrane-associated proteins.
Second, nitric oxide signaling. Experimental studies have found that EPA and DHA can influence nitric oxide production or availability under certain conditions.
Third, oxidative stress. EPA and DHA may influence pathways involved in the production and regulation of reactive oxygen species. Their effects depend on dose, cellular conditions, and the experimental model.
Fourth, inflammatory regulation. EPA and DHA are precursors to specialized pro-resolving mediators (SPMs), molecules involved in regulating the resolution of inflammation.
These processes are relevant because oxidative stress, inflammation, and impaired endothelial signaling can contribute to glycocalyx dysfunction.
Consider the potential sequence:
Inadequate EPA and DHA status may contribute to an unfavorable endothelial environment.
That environment may influence membrane signaling, nitric oxide availability, and inflammatory regulation.
These changes could potentially compromise the endothelial cell’s ability to maintain a healthy glycocalyx.
As the glycocalyx becomes impaired, its ability to support normal endothelial signaling may decline.
This could reinforce endothelial dysfunction and create a self-perpetuating cycle.
That is the connection I believe deserves further scientific investigation.
To be clear, researchers have established important parts of this biology, but they have not yet demonstrated that low EPA and DHA status initiates this entire sequence in humans.
Nor has it been established that omega-3 supplementation directly restores the glycocalyx and prevents cardiovascular events through this mechanism.
However, the hypothesis is biologically plausible and testable.
Why the Omega-6-to-Omega-3 Ratio Deserves Attention
Omega-6 and omega-3 fatty acids are both essential components of human biology.
The issue isn’t that omega-6 fatty acids are inherently harmful.
The important question is whether a person’s overall fatty acid status supports healthy cellular function.
Arachidonic acid (AA), an omega-6 fatty acid, and EPA participate in the production of signaling molecules involved in inflammatory and vascular regulation.
DHA contributes to membrane structure and cellular signaling.
The relative abundance of these fatty acids can influence certain biological pathways.
However, the omega-6-to-omega-3 ratio alone does not tell us everything.
Someone could improve their ratio by reducing omega-6 fatty acids without necessarily achieving adequate EPA and DHA levels.
That’s why I believe it’s important to evaluate actual EPA and DHA status alongside the omega-6-to-omega-3 ratio.
A red blood cell fatty acid test can provide information about longer-term fatty acid status, including the Omega-3 Index and the relative abundance of certain omega-6 and omega-3 fatty acids.
Because red blood cells circulate for approximately 120 days, their fatty acid composition provides insight into nutritional status over a period of weeks to months.
However, red blood cell membranes are not identical to endothelial cell membranes. The test does not directly establish the fatty acid composition of endothelial cells or measure glycocalyx integrity.
Nevertheless, it provides useful information that can help guide nutritional decisions..
When the Protective System Breaks Down: How Plaque Begins to Form
Now let’s connect everything we’ve discussed to cholesterol and atherosclerosis.
When the endothelial glycocalyx begins to deteriorate, the consequences may extend far beyond reduced nitric oxide production.
The glycocalyx helps regulate vascular permeability and limits certain interactions between circulating immune cells and the endothelial surface.
When this protective system becomes compromised, endothelial inflammation and abnormal permeability may increase.
Why does that matter?
Because atherosclerosis develops within the artery wall—not simply inside the open space through which blood flows.
To understand why this distinction matters, we need to look at how plaque actually forms.
Step 1: ApoB-Containing Lipoproteins Enter the Artery Wall
Cholesterol travels through the bloodstream inside particles called lipoproteins.
Some of these particles contain apolipoprotein B (ApoB), including LDL.
These particles can cross the endothelial lining and enter the inner layer of the artery wall, called the intima.
Importantly, LDL particles can enter the artery wall even when the endothelium appears intact. Glycocalyx damage is not required for this process to begin.
However, endothelial dysfunction and changes in glycocalyx integrity may influence vascular permeability and the local inflammatory environment.
Step 2: Lipoproteins Become Trapped
Once ApoB-containing particles enter the artery wall, some can bind to components of the extracellular matrix and become retained.
This is a critical step in atherosclerosis.
Retained lipoproteins can undergo modifications and stimulate inflammatory responses.
The longer this process continues, the greater the opportunity for cholesterol accumulation and plaque development.
Step 3: Inflammation Attracts Immune Cells
As the artery wall becomes inflamed, endothelial cells can express adhesion molecules that help circulating immune cells attach to the vessel lining.
Certain white blood cells, particularly monocytes, can then enter the artery wall.
Once inside, monocytes can develop into macrophages—immune cells that help clear cellular debris and other material.
Macrophages can take up modified lipoproteins and accumulate cholesterol.
When this happens, they can become foam cells, one of the characteristic features of early atherosclerotic lesions.
This is where glycocalyx integrity may become especially relevant.
A healthy glycocalyx helps regulate interactions between circulating immune cells and the endothelial surface.
When that protective layer becomes compromised, inflammatory cell adhesion and recruitment may become easier under certain conditions.
In other words, glycocalyx deterioration may help create an environment that favors the inflammatory processes involved in plaque development.
Step 4: Plaque Develops and Progresses
Over time, continued lipoprotein retention, inflammatory activity, cell death, and changes in the artery wall can contribute to the development of atherosclerotic plaque.
Some plaques develop fibrous tissue and calcification.
Others may contain large lipid-rich regions and inflammatory cells.
As plaques progress, they can narrow the artery and interfere with blood flow.
In some cases, a plaque can rupture or erode, triggering blood clot formation that may cause a heart attack or stroke.
And here’s the important connection to The Cholesterol Matrix.
The condition of the artery wall matters—not just the amount of cholesterol circulating in the bloodstream.
ApoB-containing particles play a causal role in atherosclerosis, and lowering elevated ApoB reduces cardiovascular risk.
But the biological environment of the artery wall—including endothelial function, glycocalyx integrity, blood pressure, glucose regulation, and inflammatory signaling—can also influence how vascular disease develops.
This is why I believe understanding endothelial health, insulin resistance, oxidative stress, and cellular fatty acid status is so important.
They are interconnected parts of the environment in which atherosclerosis develops.
And this brings us back to my original question:
Could inadequate EPA and DHA status contribute to endothelial dysfunction, potentially making the glycocalyx more vulnerable and creating conditions that favor atherosclerotic progression?
We don’t yet have definitive clinical evidence establishing that complete sequence.
But the question is scientifically reasonable—and worth investigating.
Can We Interrupt the Vicious Circle?
My approach to health has always emphasized a simple principle:
Once we understand what contributes to damage, we can begin addressing those contributing factors.
For the endothelial glycocalyx and endothelial cells, that means paying attention to blood glucose regulation, insulin resistance, blood pressure, oxidative stress, inflammation, smoking, physical activity, and nutritional status.
Regular exercise supports endothelial function and nitric oxide signaling.
Improving metabolic health can reduce some of the conditions associated with vascular dysfunction.
A nutrient-dense dietary pattern supports cardiovascular health.
Managing elevated ApoB and blood pressure can reduce established cardiovascular risks.
And ensuring adequate EPA and DHA intake is a reasonable nutritional objective because these fatty acids participate in cellular structure and function.
I also encourage people to understand their actual omega-3 status rather than assuming they’re getting enough simply because they occasionally eat fish or take a fish oil supplement.
The glycocalyx is a dynamic structure whose components are continually maintained and renewed.
Experimental research suggests that recovery can occur under certain conditions, although no particular nutritional intervention has yet been proven to regenerate the glycocalyx and prevent heart attacks through that mechanism.
But here’s the encouraging part.
We already know that addressing blood pressure, glucose regulation, physical inactivity, smoking, and elevated ApoB can improve cardiovascular health and reduce risk.
We don’t have to wait for every detail of glycocalyx biology to be resolved before taking meaningful steps toward better health.
Can We Actually Measure Glycocalyx Health?
Interestingly, researchers have developed methods to estimate glycocalyx barrier properties.
One approach uses specialized imaging beneath the tongue to calculate the perfused boundary region (PBR).
A measurement called PBR 5–25 evaluates red blood cell penetration patterns in small blood vessels approximately 5–25 micrometers in diameter.
Higher values generally suggest impaired glycocalyx barrier properties.
In a six-year observational study published in 2022, researchers found that glycocalyx-related measurements were associated with future adverse cardiovascular events.
This raises the possibility of studying glycocalyx health alongside ApoB, blood pressure, insulin resistance, endothelial function, and fatty acid status.
However, PBR 5–25 remains a specialized, indirect measurement rather than an established routine diagnostic test for coronary artery disease.
For me, this opens the door to an important research question:
If we improve cellular EPA and DHA status and metabolic health, will we also see measurable improvements in glycocalyx-related measurements and endothelial function?
That’s a question worth investigating.
My Cholesterol Matrix Hypothesis
Here is what I believe deserves further scientific investigation:
An unfavorable cellular fatty acid profile, particularly inadequate EPA and DHA status, may influence endothelial membrane organization, nitric oxide signaling, oxidative stress, and inflammatory regulation. These changes could contribute to endothelial dysfunction, potentially compromising the maintenance and integrity of the endothelial glycocalyx. Once the glycocalyx becomes impaired, reduced blood-flow sensing, altered endothelial signaling, increased inflammatory activity, and changes in vascular permeability may reinforce the dysfunction, creating an environment that could favor atherosclerotic progression.
The human hyperglycemia research provides an important example of how metabolic stress can rapidly affect glycocalyx-related measurements, endothelial function, and coagulation activity.
It also suggests that oxidative stress may be an important part of this relationship.
My question is whether inadequate EPA and DHA status may contribute to some of these same biological vulnerabilities through effects on endothelial membrane function and inflammatory regulation.
Could improving EPA and DHA status help create a healthier endothelial environment and potentially interrupt the cycle of glycocalyx degradation and endothelial dysfunction?
That’s the research question I believe deserves attention.
If this relationship is confirmed, it could help explain another pathway through which cellular nutrition and metabolic health influence cardiovascular disease.
This does not mean cholesterol is unimportant.
ApoB-containing lipoproteins play a causal role in atherosclerosis, and lowering elevated concentrations reduces cardiovascular risk in appropriate patients.
My hypothesis is that understanding cardiovascular disease requires us to examine both the particles circulating in the bloodstream and the biological condition of the artery wall.
That includes the endothelial cells, their plasma membranes, the glycocalyx, nitric oxide signaling, and the metabolic environment in which these systems function.
That’s The Cholesterol Matrix: understanding the interconnected systems that influence cardiovascular health rather than focusing on cholesterol in isolation.
My Final Thoughts: Your Cardiovascular Health Begins at the Cellular Level
I believe the future of cardiovascular prevention involves looking beyond any single laboratory number.
We need to understand cholesterol and ApoB, but also insulin resistance, endothelial function, nitric oxide signaling, inflammation, and cellular fatty acid status.
And we need to pay more attention to the endothelial glycocalyx.
Think about what the research has already demonstrated.
In a small human experiment, several hours of experimentally elevated blood glucose were associated with an approximately 53% reduction in estimated systemic glycocalyx volume.
At the same time, researchers observed endothelial dysfunction and increased coagulation activity.
And in separate research, scientists have described how glycocalyx damage and endothelial dysfunction may reinforce one another.
Now consider the potential role of cellular fatty acid status.
EPA and DHA influence endothelial membrane biology, inflammatory signaling, oxidative stress, and nitric oxide-related pathways.
Could inadequate amounts of these fatty acids contribute to an environment that makes endothelial cells—and the glycocalyx they maintain—more vulnerable?
That’s the question I believe we should be asking.
The science connecting these systems is fascinating, although some of the relationships I’ve proposed still require direct clinical testing.
The Cholesterol Matrix is about understanding how these interconnected systems influence cardiovascular health—and how addressing the factors we can change may help us reduce risk.
Because better cardiovascular health isn’t simply about what circulates through your arteries.
It’s also about the health of the cells and protective structures lining those arteries.
Take the First Step: Discover What’s Happening at the Cellular Level
You cannot improve what you don’t understand.
And one of the most practical places to begin is by learning more about your cellular fatty acid status.
That’s why I encourage everyone to consider starting with the At-Home Cellular Health Test.
This convenient finger-prick blood test provides valuable insight into:
✅ Your omega-6-to-omega-3 ratio: Discover the balance of these essential fatty acids in your red blood cell membranes.
✅ Your Omega-3 Index: Learn whether your red blood cells contain adequate levels of EPA and DHA.
✅ Your cellular fatty acid composition: Gain insight into fatty acid patterns that can influence membrane properties and cellular signaling.
✅ Your AA-to-EPA ratio: Better understand the balance between two fatty acids involved in inflammatory signaling.
✅ Your starting point for improvement: Establish a baseline so you can make informed nutritional changes and monitor your progress over time.
The test measures red blood cell fatty acid status rather than directly measuring endothelial glycocalyx integrity or cardiovascular plaque. Nevertheless, understanding your EPA and DHA status is a useful first step toward making more informed nutritional decisions.
My message is simple: Don’t wait until you experience a cardiovascular problem to become more informed about your health.
Start by understanding your cellular fatty acid status, then take steps to improve the factors you can control.
Have Questions? Let’s Connect.
Whether you’re concerned about cholesterol, cardiovascular health, inflammation, or simply want to better understand what’s happening inside your body, I welcome your questions.
If you’re ready to take a proactive step toward better health, I encourage you to begin with the At-Home Cellular Health Test.
Email me at robert@dietfreelife.com to ask questions, learn more about the test, or discuss how to get started.
Better health begins with better information—and the decisions you make with it.
References
-
- Nieuwdorp, M., et al. (2006). Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes, 55(2), 480–486. https://pubmed.ncbi.nlm.nih.gov/16443784/
- Zhang, X., et al. (2018). Endothelial cell dysfunction and glycocalyx – A vicious circle. Matrix Biology, 71–72, 421–431. https://pubmed.ncbi.nlm.nih.gov/29408548/
- Glycocalyx in atherosclerosis-relevant endothelium function and as a therapeutic target. (2017). Current Atherosclerosis Reports. https://pubmed.ncbi.nlm.nih.gov/29127504/
- Impaired endothelial glycocalyx predicts adverse outcome in subjects without overt cardiovascular disease: A 6-year follow-up study. (2022). Journal of Cardiovascular Translational Research. https://pubmed.ncbi.nlm.nih.gov/34713396/
- Weinbaum, S., Tarbell, J. M., & Damiano, E. R. (2007). The structure and function of the endothelial glycocalyx layer. Annual Review of Biomedical Engineering, 9, 121–167. https://doi.org/10.1146/annurev.bioeng.9.060906.151959
__________
Robert Ferguson is a California- and Florida-based single father of two daughters, clinical nutritionist, Omega Balancing Coach™, researcher, best-selling author, speaker, podcast and television host, health advisor, NAACP Image Award Nominee, creator of the Diet Free Life methodology, and Chief Nutrition Officer for iCoura Health. He also serves on the Presidential Task Force on Obesity for the National Medical Association and the Health and Product Advisory Board for Zinzino, Inc.
🗓️ Schedule a FREE consultation with Robert Ferguson about becoming a client: SCHEDULE FREE CONSULTATION
👉🏽 To order the BalanceOil+ with the BalanceTEST, > CLICK HERE
👉🏽 Watch a free online presentation on the BalanceOil+ and the BalanceTEST: WATCH NOW.
0 Comments